Vaccination issues in patients with chronic kidney disease (Q38176987)

30 August 2017

title

Vaccination issues in patients with chronic kidney disease (English)

1 reference

30 August 2017

Roy Mathew

1

1 reference

30 August 2017

Darius Mason

series ordinal

2

1 reference

30 August 2017

Jeffrey S Kennedy

series ordinal

3

1 reference

30 August 2017

publication date

3 January 2014

1 reference

Expert Review of Vaccines

30 August 2017

published in

1 reference

30 August 2017

volume

13

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

285-298

1 reference

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Pulmonary infectious mortality among patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Infectious complications in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Mortality of dialysis patients according to influenza and pneumococcal vaccination status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Immunologic defects and vaccination in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

The role of tubulointerstitial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Aspects of immune dysfunction in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Vaccine Adjuvants: Putting Innate Immunity to Work

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Effect of uremia on structure and function of immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Targeting the innate immune response with improved vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Levamisole is a potential facilitator for the activation of Th1 responses of the subunit HBV vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

The adjuvant effect of levamisole on killed viral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Targeting nanoparticles to dendritic cells for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

B cell-associated immune profiles in patients with end-stage renal disease (ESRD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

The prevalence of hepatitis B virus infection in the United States in the era of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Hepatitis B virus infection and the dialysis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Review article: Hepatitis B and dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Efficacy of GM-CSF as an Adjuvant to Hepatitis B Vaccination in Patients with Chronic Renal Failure—Results of a Prospective, Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Multistate outbreak of hepatitis A associated with frozen strawberries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Hepatitis A outbreak activity in the United States: responding to a vaccine-preventable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Clinical features and outcomes of acute kidney injury among patients with acute hepatitis A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

What factors determine the severity of hepatitis A‐related acute liver failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Influenza vaccination in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Influence of renal replacement therapy on immune response after one and two doses of the A(H1N1) pdm09 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Antibody response after single H1N1 influenza vaccine in chronic dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Human infection with a novel avian-origin influenza A (H7N9) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Pneumonia in incident dialysis patients--the United States Renal Data System

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: a prospective study of safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Spontaneous corynebacterium discitis in a patient with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

A review of the varicella vaccine in immunocompromised individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

On DNA vaccines and prolonged expression of immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Long-term persistence of hepatitis B surface antigen and antibody induced by DNA-mediated immunization results in liver and kidney lesions in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.874950

10.1586/14760584.2014.874950

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference